Charles Schwab’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $767K | Buy |
68,849
+29,612
| +75% | +$330K | ﹤0.01% | 2986 |
|
|
2025
Q1 | $482K | Buy |
39,237
+2,700
| +7% | +$33.2K | ﹤0.01% | 3097 |
|
|
2024
Q4 | $409K | Hold |
36,537
| – | – | ﹤0.01% | 3201 |
|
|
2024
Q3 | $255K | Hold |
36,537
| – | – | ﹤0.01% | 3310 |
|
|
2024
Q2 | $276K | Buy |
+36,537
| New | +$276K | ﹤0.01% | 3387 |
|
|
2022
Q2 | – | Sell |
-16,968
| Closed | -$140K | – | 3610 |
|
|
2022
Q1 | $140K | Sell |
16,968
-480
| -3% | -$3.96K | ﹤0.01% | 3362 |
|
|
2021
Q4 | $176K | Hold |
17,448
| – | – | ﹤0.01% | 3375 |
|
|
2021
Q3 | $277K | Hold |
17,448
| – | – | ﹤0.01% | 3280 |
|
|
2021
Q2 | $416K | Buy |
+17,448
| New | +$416K | ﹤0.01% | 3199 |
|